Centennial Surgical Suture Limited announced its un-audited financial results for the quarter and half-year ended September 30, 2026. The company reported a profit before tax of ₹190.10 lakhs for the period. Additionally, the Board of Directors considered and approved the financial results, alongside taking on record the resignation of Anuradha Kashikar as Whole Time Director. The Board also considered a proposal for raising funds through various permissible modes.
Financial Results and Key Decisions for Q2 2026
Centennial Surgical Suture Limited has officially released its un-audited financial results for the quarter and half-year ending September 30, 2026. The company reported a profit before tax amounting to ₹190.10 lakhs for the period. This figure was part of the comprehensive financial review undertaken by the Board of Directors.
Board Meeting Highlights
During the Board meeting held on November 12, 2026, the Directors also took on record the resignation of Anuradha Kashikar from her position as Whole Time Director, effective October 5, 2026. The Board expressed sincere appreciation for her valuable services and contributions to the company. Furthermore, the Board deliberated on a proposal concerning fundraising through various permissible modes, deciding to undertake an independent assessment before making any further decisions. The financial results and the proposal for fundraising are in line with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Standalone Financial Performance
The standalone un-audited financial results include the Statement of Assets and Liabilities and Cash Flow Statement for the half-year ended September 30, 2026. The detailed financial statements, along with the Limited Review Report from the Statutory Auditors, have been made available on the BSE website and the company’s website.
Source: BSE
